NM_000455.5:c.460C>G
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PP3_ModeratePP5
The NM_000455.5(STK11):c.460C>G(p.His154Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000455.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STK11 | NM_000455.5 | c.460C>G | p.His154Asp | missense_variant | Exon 3 of 10 | ENST00000326873.12 | NP_000446.1 | |
STK11 | NM_001407255.1 | c.460C>G | p.His154Asp | missense_variant | Exon 3 of 9 | NP_001394184.1 | ||
STK11 | NR_176325.1 | n.1727C>G | non_coding_transcript_exon_variant | Exon 4 of 11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STK11 | ENST00000326873.12 | c.460C>G | p.His154Asp | missense_variant | Exon 3 of 10 | 1 | NM_000455.5 | ENSP00000324856.6 | ||
STK11 | ENST00000652231.1 | c.460C>G | p.His154Asp | missense_variant | Exon 3 of 9 | ENSP00000498804.1 | ||||
STK11 | ENST00000585748.3 | c.88C>G | p.His30Asp | missense_variant | Exon 5 of 12 | 3 | ENSP00000477641.2 | |||
STK11 | ENST00000593219.5 | n.*285C>G | downstream_gene_variant | 3 | ENSP00000466610.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 39
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.H154D variant (also known as c.460C>G), located in coding exon 3 of the STK11 gene, results from a C to G substitution at nucleotide position 460. The histidine at codon 154 is replaced by aspartic acid, an amino acid with similar properties. This alteration has been observed in multiple individuals with a personal and/or family history that is consistent with Peutz-Jeghers syndrome (Zhao X et al. Nan Fang Yi Ke Da Xue Xue Bao, 2012 Apr;32:511-4; Ambry internal data). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Peutz-Jeghers syndrome Uncertain:1
This sequence change replaces histidine with aspartic acid at codon 154 of the STK11 protein (p.His154Asp). The histidine residue is highly conserved and there is a moderate physicochemical difference between histidine and aspartic acid. This variant has been reported in an individual affected with Peutz-Jeghers syndrome (PMID: 22543132). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. In summary, this is a rare missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. This variant is not present in population databases (ExAC no frequency). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at